What is EnginZyme?
EnginZyme is at the forefront of sustainable manufacturing, aiming to make biobased technology accessible across diverse industries. The company's core innovation lies in its patented cell-free technology platform, which harnesses the catalytic power of enzymes. By merging biological processes with chemical industry efficiency, EnginZyme offers a superior alternative to traditional fossil-based manufacturing. This approach is designed to accelerate the global transition towards more environmentally responsible production of essential products, positioning EnginZyme as a key player in the green technology sector.
How much funding has EnginZyme raised?
EnginZyme has raised a total of $35.3M across 2 funding rounds:
Series A
$13M
Series B
$22.3M
Series A (2021): $13M with participation from Industrifonden, Sofinnova Partners, and SEB Greentech
Series B (2022): $22.3M led by Sofinnova Partners and Industrifonden
Key Investors in EnginZyme
Industrifonden
Industrifonden is a Swedish venture capital fund that invests in unique, scalable innovations aimed at improving society through breakthrough technologies and science, focusing on deep tech and life sciences.
Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability, acting as a hands-on company builder across the entire value chain of life sciences investments.
SEB Greentech
SEB Greentech is an investor focused on supporting environmentally conscious technologies and sustainable business models within the green technology sector.
What's next for EnginZyme?
The substantial enterprise-level funding and recent strategic investment signal a new phase of accelerated growth and market penetration for EnginZyme. With this capital infusion, the company is poised to scale its operations, further develop its enzyme technology, and expand its reach into new markets. The backing from prominent investors like Sofinnova Partners and Industrifonden, known for their focus on deep tech and life sciences, suggests a strategic emphasis on further innovation and commercialization. EnginZyme's trajectory indicates a strong potential to disrupt traditional chemical manufacturing and lead the charge in sustainable industrial practices.
See full EnginZyme company page
